| Abbreviation | Definition |
| AE | Adverse event |
| AIT | Allergen immunotherapy |
| AR | Allergic rhinitis |
| ARIA | Allergic Rhinitis and its Impact on Asthma |
| ARC | Allergic rhinoconjunctivitis |
| CSMS | Combined Symptom and Medication Score |
| CTIS | Clinical Trials Information System |
| DBPC | Double-blind, placebo-controlled |
| dMS | Daily Medication Score |
| dSS | Daily Symptom Score |
| DWD | Deutscher Wetterdienst |
| EAACI | European Academy of Allergy and Clinical Immunology |
| E-Set | Eligible Set |
| ICH-GCP | International Council for Harmonisation Good Clinical Practice |
| IgE | Immunoglobulin E |
| ITT | Intention-to-treat |
| NPT | Nasal provocation test |
| PRO | Patient-reported outcome |
| QoL | Quality of Life |
| RQLQ | Rhinoconjunctivitis Quality of Life Questionnaire |
| SCIT | Subcutaneous allergen-specific immunotherapy |
| SD | Standard deviation |
| SLIT | Sublingual immunotherapy |
| SPT | Skin prick test |